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Abstract Uncoupling protein 3L, uncoupling protein 1 and the
mitochondrial oxoglutarate carrier were expressed in Saccha-
romyces cerevisae. Effects on different parameters related to the
energy expenditure were studied. Both uncoupling protein 3L and
uncoupling protein 1 reduced the growth rate by 49% and 32%
and increased the whole yeast O2 consumption by 31% and 19%,
respectively. In isolated mitochondria, uncoupling protein 1
increased the state 4 respiration by 1.8-fold, while uncoupling
protein 3L increased the state 4 respiration by 1.2-fold.
Interestingly, mutant uncoupling protein 1 carrying the H145Q
and H147N mutations, previously shown to markedly decrease
the H+ transport activity of uncoupling protein 1 when assessed
using a proteoliposome system (Bienengraeber et al. (1998)
Biochem. 37, 3^8), uncoupled the mitochondrial respiration to
almost the same degree as wild-type uncoupling protein 1. Thus,
absence of this histidine pair in uncoupling protein 2 and
uncoupling protein 3 does not by itself rule out the possibility that
these carriers have an uncoupling function. The oxoglutarate
carrier had no effect on any of the studied parameters. In
summary, a discordance exists between the magnitude of effects
of uncoupling protein 3L and uncoupling protein 1 in whole yeast
versus isolated mitochondria, with uncoupling protein 3L having
greater effects in whole yeast and a smaller effect on the state 4
respiration in isolated mitochondria. These findings suggest that
uncoupling protein 3L, like uncoupling protein 1, has an
uncoupling activity. However, the mechanism of action and/or
regulation of the activity of uncoupling protein 3L is likely to be
different.
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1. Introduction
Uncoupling proteins (UCPs)2 are closely related mitochon-
drial inner membrane proteins. UCP1 was the ¢rst UCP to be
identi¢ed [1^3]. Its biochemical function has been character-
ized extensively. UCP1 uncouples the mitochondrial respira-
tion from ATP synthesis by dissipating the transmembrane
proton gradient [4^6]. The mechanism of uncoupling is
thought to be due to either direct transport of protons by
UCP1 [7] or, alternatively, transport of free fatty acids anions
by UCP1, allowing free fatty acids to function as cycling
protonophores [8,9]. The uncoupling activity of UCP1 is in-
hibited by purine nucleotides, such as GDP [4]. UCP1, which
is expressed exclusively in brown adipose tissue, is believed to
play an important role in the thermogenesis in rodents. Its
role in humans is less certain as the mass of brown adipose
tissue is less abundant.
Recently, two proteins with 59% and 57% homology to
UCP1 were identi¢ed, UCP2 [10,11] and UCP3 [12^14]. The
UCP3 gene generates two mRNA transcripts, UCP3L, which
encodes a protein similar in length to UCP1 and UCP2, and
UCP3S, which encodes a protein lacking the last 37 C-termi-
nal residues [12,15]. UCP2 is expressed in many tissues, while
UCP3 in humans is found predominantly in skeletal muscle.
Since skeletal muscle is believed to be a major site of adaptive
thermogenesis in humans [16^20], UCP3 could be a regulator
of the energy expenditure. However, to date, the biochemical
function and regulation of UCP3 and UCP2 are not fully
understood. Flow cytometry studies employing mitochondrial
membrane potential-sensitive dyes indicate that UCP2 [10,11]
and UCP3L [14,21,22] decrease the mitochondrial membrane
potential. In addition, Fleury et al. [10] found that UCP2
increased the state 4 respiration in yeast mitochondria.
Recently, Bienengraeber et al. [23] found that the H trans-
port activity by UCP1, assessed by reconstitution of UCP1
into proteoliposomes, is almost completely abolished when
histidine residues H145 and H147 are mutated to neutral res-
idues and reduced to about 10% when only one of the two
histidines is mutated. Of note, this histidine pair is absent in
UCP2 and human UCP3 lacks the equivalent histidine, H145.
It was predicted, therefore, that the H transporting activity
of UCP2 and UCP3 would be greatly diminished or require a
di¡erent mechanism [23].
In the present study, we have utilized a yeast expression
system to explore the biochemical function of UCP3L. To-
wards these ends, we have generated a recombinant yeast ex-
pressing UCP3L under the control of a galactose inducible
promoter. For the purposes of comparison, we have also gen-
erated a yeast expressing UCP1, a carrier which has uncou-
pling activity, the double histidine mutant of UCP1 (H145Q
and H147N) previously demonstrated to be defective in the
proton transport in a proteoliposome system [23] and the
oxoglutarate carrier, which mediates an electroneutral ex-
change of oxoglutarate for malate [24]. The oxoglutarate car-
rier should be informative as a negative control, particularly
since it is most homologous to UCP1, UCP2 and UCP3L
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(31% identical), but is thought to lack uncoupling activity.
These yeasts have been used to assess the e¡ects of carrier
expression on growth rates and the basal O2 consumption in
whole yeast and on the state 4 respiration in isolated mito-
chondria. Our data indicate that UCP3L has an uncoupling
activity but is regulated di¡erently from UCP1.
2. Materials and methods
2.1. Expression vectors and site-directed mutagenesis
Human UCP3L, rat UCP1 and human mitochondrial oxoglutarate
carrier encoding sequences were obtained using PCR ampli¢cation
and corresponding cDNA templates. The PCR primers used are
shown in Table 1.
The oligonucleotides were designed to introduce Hind III and Xba I
sites close to the ATG (start) and TAG or TGA (stop) codons, re-
spectively. After ampli¢cation and digestion with Hind III and Xba I,
the PCR products were introduced into the pYES2 expression vector
(Invitrogen, Carlsbad, CA, USA) in which the carrier gene expression
is under the control of the gal10-cyc1 promoter. The H145Q and
H147N double histidine mutant of UCP1 was generated using site-
directed mutagenesis (Quickchange site-directed mutagenesis kit, Stra-
tagene, La Jolla, CA, USA). As described in [23], the codons for H145
(CAT) and H147 (CAC) were changed to CAG (codon for glutamine)
and AAC (codon for asparagine), respectively.
In addition, epitope constructs, using an in£uenza virus hemagglu-
tinin epitope tag, were prepared as described in [25]. The epitope tag
was added at the N-terminus of the mitochondrial carrier protein
sequence.
All sequences were veri¢ed by DNA sequencing. Site-directed muta-
genesis of mutant UCP1 was also con¢rmed by RT-PCR of isolated
yeast RNA, followed by DNA sequencing.
The Saccharomyces cerevisiae strain INVSC1 (Invitrogen) was
transformed with the pYES2 vectors containing these constructs.
The empty pYES2 vector was transformed as an additional negative
control.
2.2. Expression of the UCPs and the oxoglutarate carrier
Yeast transformants were selected on SC-ura plates. Single colonies
were inoculated into a preculture grown in SC-ura medium (0.67%
yeast nitrogen base, 0.1% KH2PO4, 0.12% (NH4)2SO4, 0.1% glucose,
2% lactate, 0.1% casamino acids, 20 mg/l tryptophan, 40 mg/l ad-
enine) to an OD600 of 2^4. Glucose was added in order to maintain
a complete repression of the Gal-Cyc promoter during growth. The
yeasts were diluted to a ¢nal OD600 of 0.04 in 500 ml of the same
medium except that glucose was absent and lactate was present at a
concentration of 3% and grown at 30‡C with vigorous shaking to
ensure good oxygenation. After approximately 36 h, 1% galactose
was added and the cells were harvested after 8^12 h.
2.3. Analysis of expression of the UCPs and the oxoglutarate carrier by
Western blotting
The expression of the UCPs was detected by Western blotting with
the respective antibodies. A rabbit anti-mouse UCP1 IgG fraction was
purchased from RDI Research Diagnostics (Flanders, NJ, USA). The
antibody to human UCP3 was prepared against a peptide representing
residues 147^166 in exon 4. The antibody was a⁄nity-puri¢ed by the
same peptide coupled to Pierce SulfoLink gel.
Western blotting of mitochondrial protein from the yeast expressing
the epitope tag-coupled proteins was performed using mouse mono-
clonal antibody (clone 12CA5) to the peptide epitope derived from the
hemagglutinin protein of human in£uenza virus (Boehringer Mann-
heim, Indianapolis, IN, USA).
2.4. Whole yeast O2 consumption
Yeasts were harvested, washed once and resuspended in 3% lactate
containing SC growth medium at approximately 2.5U109 cells/ml.
The basal O2 consumption and maximum O2 consumption induced
with 2 WM carbonyl cyanide p-(tri£uoromethoxy)phenylhydrazone
(FCCP) were measured in a Clarke type oxygen electrode chamber
at 25‡C with 1 ml of cell suspension at a ¢nal concentration of
2.5U108 cells/ml in the 3% lactate SC medium.
2.5. Measurement of the mitochondrial membrane potential of yeast
expressing UCPs and oxoglutarate carrier
The mitochondrial membrane potential was measured with the po-
tential-sensitive dye 3P3-dihexyloxacarbocyanine iodide (DiOC6) (Mo-
lecular Probes, Eugene, OR, USA) at a concentration of 25 nM.
When indicated, 10 WM FCCP was added 5^10 min before the addi-
tion of DiOC6. Cells were counted (10 000 events) approximately 30
min after the addition of DiOC6 using a FACScan instrument (Becton
Dickinson, Cockeysville, MD, USA).
2.6. Isolation of yeast mitochondria
Mitochondria were prepared as described by Arechaga et al. [26].
Spheroplasts were prepared by enzymatic digestion with zymolyase
and mitochondria were isolated by di¡erential centrifugation after
homogenization of the spheroplasts. The bu¡er for mitochondrial
isolation contained 0.6 M mannitol, 10 mM Tris/maleate pH 7.4,
0.1% bovine serum albumin (BSA), 1 mM phenylmethylsulfonyl£uo-
ride (PMSF), 1 mM ethylenebis(oxyethylenenitrilo)tetraacetic acid
(EGTA) and 1 mM ethylenediaminetetraacetic acid (EDTA). BSA
and PMSF were omitted during the last washing step. The mitochon-
dria were resuspended in the isolation bu¡er without BSA and PMSF
at a ¢nal protein concentration of approximately 10 mg/ml.
2.7. Polarography
The mitochondrial respiration was measured in a Clarke type oxy-
gen electrode at 30‡C under the following standard incubation con-
ditions: 0.6 M mannitol, 10 mM Tris/maleate pH 6.8, 5 mM
KH2PO4/K2HPO4, 0.5 mM EDTA, 3 mM NADH, 2.5 Wg/ml oligo-
mycin and approximately 0.25 mg mitochondrial protein/ml.
2.8. Statistical analysis
Statistical analysis was performed using StatView 4.0 (Abacus Con-
cept, Berkeley, CA, USA). All results are presented as the mean þ S.E.
The student’s t test was used to evaluate the statistical signi¢cance of
di¡erences, as indicated in the ¢gure and table legends.
Table 1
Primers for PCR ampli¢cation of mitochondrial carriers
UCP3L
(Sense) 5P-AAGCTTGAATTCATGGTTGGACTGAAGCCTCAGAC
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3. Results
3.1. Expression of the UCPs and the oxoglutarate carrier
Expression of UCP3L, UCP1 and mutant UCP1 was con-
¢rmed by Western blot analysis of isolated mitochondria, ob-
tained 8 h after induction with 1% galactose (Fig. 1A). For
UCP3L, the relative abundance of protein in whole yeast as
compared to isolated mitochondria was also measured (Fig.
1B). The isolated mitochondria contained at least 10-fold
more UCP3L on a per protein basis, demonstrating that
UCP3L was targeted to mitochondria.
Since no suitable antibody against the oxoglutarate carrier
was available, the presence of oxoglutarate carrier RNA was
con¢rmed by Northern blot analysis (data not shown). In
order to con¢rm that human oxoglutarate carrier protein
can be expressed by yeast and to compare the expression
levels of the various mitochondrial carriers, epitope tag con-
structs for UCP3L, UCP1 and the oxoglutarate carrier were
made and expressed in yeast. Western blot analysis of isolated
mitochondria in Fig. 1C shows that all three proteins were
expressed at qualitatively similar levels.
3.2. The e¡ect of UCPs on growth
Both UCP3L and UCP1 inhibited the growth of aerobically
grown yeast (Fig. 2). The data in Fig. 2 represent one typical
experiment. The average inhibition of growth by UCP3L, in
comparison to control yeast, was 49 þ 4% (n = 7) after growth
for 14 h. UCP1 had an intermediate e¡ect on growth (32 þ 5%
inhibition). The oxoglutarate carrier had no inhibitory e¡ect
on growth.
3.3. The e¡ect of UCPs on whole yeast O2 consumption
UCP3L and UCP1 increased the basal O2 consumption of
whole yeast by 31% and 19%, respectively (Table 2). The
oxoglutarate carrier had no e¡ect on the basal O2 consump-
tion. The uncoupling agent, FCCP, increased the O2 con-
sumption of all yeast strains to a similar absolute rate (ap-
proximately 100 nmol O/min/108 cells). The ability of UCP1
and UCP3L to increase the basal but not maximally un-
coupled respiration is consistent with UCP1 and UCP3L hav-
ing a partial uncoupling activity.
3.4. The e¡ect of UCPs on the mitochondrial membrane
potential
Both UCP3L and UCP1 decreased the DiOC6 uptake as
measured by £ow cytometry (Fig. 3). Expression of the oxo-
glutarate carrier resulted in a slight decrease in the DiOC6
£uorescence. This decrease in DiOC6 uptake induced by ox-
oglutarate carrier expression was consistently less than that
observed with UCP3L and UCP1.
3.5. The e¡ect of UCPs in isolated mitochondria
To study the e¡ect of UCP3L in isolated mitochondria, the
capacity of UCP3L to uncouple the oxidative phosphoryla-
tion was compared with that of UCP1. The state 4 respiration
was measured in the presence of oligomycin to inhibit ATP
synthase. Typical tracings for the empty vector control, UCP1
and UCP3L are shown in Fig. 4a. Fig. 4b shows state 4
respiratory rates in the absence and presence of GDP and
Fig. 1. (A, B) Immunoblot analysis of the expression of the UCPs.
(C) Immunoblot analysis of the expression of UCP1, UCP3L and
the oxoglutarate carrier in isolated mitochondria using epitope tag
constructs expressed in yeast. 40 Wg mitochondrial protein was used
for analysis in each lane.
Fig. 2. The growth rate of yeast expressing UCP3L, UCP1 and the
oxoglutarate carrier. Yeasts were grown at 30‡C in 3% lactate and
no glucose containing growth medium as described under section 2.
At time zero, yeasts were diluted with growth medium to an OD600
of 0.20 and galactose was added (¢nal concentration of 1%). The
growth was measured by determining the absorption at 600 nm. (b)
control (empty vector); (v) UCP3L; (a) UCP1; (F) oxoglutarate
carrier. The experiment was repeated seven times with similar re-
sults. Means and standard errors are given in the text. One typical
experiment is presented.
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maximally uncoupled respiratory rates after the addition of
FCCP. As expected, UCP1 increased the state 4 respiration by
approximately 2-fold. The small increase of the state 4 respi-
ration observed with UCP3L was not signi¢cant. The oxoglu-
tarate carrier had no e¡ect on the state 4 respiration. Of note,
both UCP1 and UCP3L, but not the oxoglutarate carrier,
decreased the maximally uncoupled respiration in the presence
of FCCP. To correct for the di¡erent maximum respiratory
activities and the day to day variation of mitochondrial prep-
arations, the results in Fig. 4c were expressed as percentage of
the FCCP-stimulated respiration. The increase in state 4 in-
duced by UCP3L, when expressed as percentage of the FCCP-
stimulated respiration, is statistically signi¢cant compared to
the empty vector and oxoglutarate carrier controls. 1 mM
GDP blocked the increase of the state 4 respiration with
UCP1 completely, but had no e¡ect on the state 4 respiration
in mitochondria bearing UCP3L.
We also studied the e¡ect of a modi¢ed version of UCP1
carrying the H145Q and H147N mutations, previously shown
by Bienengraeber et al. [23] to have a markedly decreased H
transport activity in proteoliposomes. Unexpectedly, mutant
UCP1 uncoupled the mitochondrial respiration to almost the
same degree as UCP1. This uncoupling activity is speci¢c,
since it was completely blocked by GDP (Fig. 4d).
4. Discussion
UCP1 plays an important role in the adaptive thermogen-
esis by uncoupling the mitochondrial respiration from ATP
synthesis and increasing the energy expenditure [5,6]. Based
on the high sequence homology between UCP1 and UCP3L,
it was predicted that UCP3L would have a similar function
[12,13,14]. However, except for a UCP3L-induced decrease in
the mitochondrial membrane potential [14,21,22], the bio-
chemical function of UCP3L has not yet been established.
In the present study, UCP3L expression reduced the growth
and increased the whole yeast basal O2 consumption. These
e¡ects of UCP3L in whole yeast were even stronger than
those observed with UCP1. Although these parameters are
not speci¢c for the uncoupling activity, the fact that the
well-characterized UCP1 had similar e¡ects, while the oxoglu-
tarate carrier had no e¡ect, suggests that the two UCPs have
similar biochemical activities.
Expression of UCP3L and UCP1 decreased the DiOC6 up-
take by whole yeast, as assessed using £ow cytometry. How-
ever, expression of the oxoglutarate carrier also decreased the
DiOC6 uptake albeit to a much smaller degree. Given that the
DiOC6 £uorescence depends on both the mitochondrial mem-
brane potential and the amount of mitochondria present in
yeast, our data raise the possibility that some portion of this
measurement may be prone to non-speci¢c e¡ects. Alterna-
Fig. 3. The mitochondrial membrane potential of yeast expressing
UCPs and oxoglutarate carrier. Fluorescence histograms of cells ex-
pressing UCP1, UCP3L, oxoglutarate carrier and empty vector are
presented. In each panel the left most histogram (light line) shows
the e¡ects of the uncoupler FCCP and the right most histogram
(light line) shows the cells with empty vector treated with DiOC6.
The dark lines show the cells with UCPs or oxoglutarate carrier
treated with DiOC6.
Table 2






(% of rate with FCCP)
Control (n = 11) 46.2 þ 1.3 104.0 þ 3.2 44.6 þ 1.2
UCP1 (n = 11) 54.8 þ 3.7* 96.3 þ 6.2 56.9 þ 1.5**
UCP3L (n = 11) 60.7 þ 3.7* 99.5 þ 5.7 61.3 þ 3.4**
Oxogl. (n = 4) 47.7 þ 3.9 104.9 þ 11.9 45.5 þ 2.6
The whole yeast O2 consumption was measured in the 3% lactate containing medium. 2 WM FCCP was added to determine the maximum res-
piratory capacity. *P6 0.01 versus the empty vector (Control) and oxoglutarate carrier (Oxogl.) controls.
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tively, the oxoglutarate carrier may have an e¡ect on the
membrane potential unrelated to uncoupling of the mitochon-
drial respiration.
To directly assess the uncoupling activity of UCP3L, the
state 4 respiration (i.e. respiration in the absence of exogenous
ADP) was measured in isolated mitochondria. Oligomycin
was added to ensure that endogenous ADP would not stim-
ulate ATP synthase. UCP1 expression produced a large in-
crease in the state 4 respiratory rate, expressed as nmol O/
min/mg mitochondrial protein (Fig. 4b). A small, not signi¢-
cant increase was observed with UCP3. Of note, the maxi-
mum respiratory rate in the presence of FCCP was decreased
in mitochondria containing UCP1 and UCP3L, although this
decrease was not signi¢cant. When results were expressed as
percentage of the FCCP-stimulated respiration (Fig. 4c),
UCP3L increased the state 4 respiration signi¢cantly in com-
parison to that observed in empty vector and oxoglutarate
carrier controls. This ¢nding is consistent with UCP3L having
uncoupling activity.
While GDP inhibited uncoupling induced by UCP1 com-
pletely, GDP at a concentration of 1 mM did not reverse the
uncoupling activity of UCP3L. Since the increase in the state
4 respiration with UCP3L was small, a partial GDP inhibition
cannot be ruled out. However, our data indicate that GDP
does not inhibit UCP3L with an a⁄nity similar to that for
GDP inhibition of UCP1, suggesting a di¡erent regulation of
UCP1 and UCP3L.
In contrast to the stronger e¡ect of UCP3L compared to
UCP1 in whole yeast cells (inhibition of the growth rate, 49%
versus 32%; stimulation of O2 consumption, 31% versus 19%),
Fig. 4. Respiration in isolated mitochondria. (a) Mitochondrial respiration was measured as described under section 2. Representative tracings
for the empty vector control (Control), UCP1 and UCP3L are shown. The addition of 3 mM NADH, 2.5 Wg/ml oligomycin, 1 mM GDP and
2.5 WM FCCP as well as the O2 consumption in nmol O/min/mg mitochondrial protein are indicated. (b) State 4 respiratory rates in the ab-
sence and presence of 1 mM GDP and respiratory rates in the presence of 2.5 WM FCCP are expressed in nmol O/min/mg mitochondrial pro-
tein. (c) State 4 respiratory rates are expressed as percentage of the maximally uncoupled respiratory rate in the presence of FCCP. The data
in b and c represent the average of ¢ve experiments. *P6 0.05; **P6 0.0001 versus the empty vector (Control) and oxoglutarate carrier (Ox-
ogl.) controls. (d) State 4 respiration with mutant UCP1 (mUCP1). State 4 respiratory rates are expressed as percentage of the maximally un-
coupled respiratory rate in the presence of FCCP. The data represent the average of three experiments. **P6 0.0001 versus the empty vector
control.
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UCP3L uncoupled the respiration in isolated mitochondria to
a much lesser degree than UCP1. This discrepancy could be
due to the fact that UCP1 in whole cells is inhibited by the
presence of endogenous purine nucleotides, that were absent
when isolated mitochondria were studied. On the other hand,
it is possible that one or more unidenti¢ed endogenous acti-
vators of UCP3L are present in whole yeast but are missing
under the incubation conditions of isolated mitochondria. Our
contrasting ¢ndings of the e¡ects of UCP1 and UCP3L in
whole yeast cells and in isolated mitochondria, as well as
the di¡erence in GDP inhibition of the two proteins, suggest
that the biochemical regulation of UCP3L is distinct from
UCP1.
We also studied the double histidine mutant of UCP1 in
isolated mitochondria. This mutant was shown previously by
Bienengraeber et al. [23] to have a greatly reduced H trans-
port activity after reconstitution into proteoliposomes. In con-
trast, our measurements of the state 4 respiration in isolated
mitochondria indicate a similar, only slightly smaller e¡ect of
mutant UCP1 compared to wild-type UCP1. This suggests
that although the histidine pair is required for the maximum
H transport activity in proteoliposomes [23], it is not essen-
tial for stimulation of state 4 respiration in isolated mitochon-
dria. Thus, a lack of this histidine pair in UCP2 and UCP3
does not by itself rule out the possibility that these carriers are
uncoupling proteins.
In summary, our data indicate that UCP3L has an uncou-
pling activity when expressed in yeast. The mechanism and
regulation of UCP3L-induced uncoupling of the mitochon-
drial respiration appears to be di¡erent from UCP1 since
the e¡ects of UCP1 and UCP3L in whole yeast versus isolated
mitochondria are discordant. The fact that both UCP1 and
UCP3L, but not the oxoglutarate carrier, have an uncoupling
activity demonstrates biochemically that they belong to a sub-
family of the much larger mitochondrial carrier superfamily.
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